Literature DB >> 19728855

Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals.

Edyta Reszka1, Jolanta Gromadzinska, Ewa Jablonska, Wojciech Wasowicz, Zbigniew Jablonowski, Marek Sosnowski.   

Abstract

BACKGROUND: Low concentrations of selenium (Se) in humans have been associated with risk of cancer. Selenoprotein mRNAs can potentially be regulated by Se status.
METHODS: Se status, GPx1 Pro198Leu and Sep15 1125G/A genetic polymorphism and human (h)GPx1, hGPx3, hSep15 and hSeP1 transcript levels in peripheral leukocytes of 33 males with bladder cancer and 47 healthy male controls were analysed.
RESULTS: All the subjects expressed detectable selenoprotein mRNA concentrations in leukocytes. Significantly lower expression of hGPx1, hGPx3, hSep15 and hSeP1 in leukocytes of bladder cancer patients compared to controls was observed. hGPx1, hGPx3 and hSep15 expression was significantly lower in non-smokers in the control group compared with smokers in the control group. A positive relationship between expression of all studied genes was also observed in non-smoking controls. Expression of hGPx3 and hSep15 gradually increased with tumour grade in patients with cancer. We did not find any association between selenoprotein mRNA levels, Se status and selenoprotein genetic polymorphism.
CONCLUSIONS: This study showed significant down-regulation of hGPx1, hGPx3, hSep15 and hSeP1 mRNA levels in leukocytes of patients with bladder cancer compared to controls. Selenoprotein transcript levels in circulating leukocytes of patients with bladder cancer and controls revealed no potential impact of Se status on selenoprotein expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728855     DOI: 10.1515/CCLM.2009.261

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

Review 1.  Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.

Authors:  Edith Lubos; Joseph Loscalzo; Diane E Handy
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

2.  GPx-1 polymorphism (rs1050450) contributes to tumor susceptibility: evidence from meta-analysis.

Authors:  Jiawei Chen; Qiang Cao; Chao Qin; Pengfei Shao; Yilong Wu; Meilin Wang; Zhengdong Zhang; Changjun Yin
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-13       Impact factor: 4.553

3.  GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt.

Authors:  David Goerlitz; Mai El Daly; Mohamed Abdel-Hamid; Doa'a A Saleh; Lenka Goldman; Sherif El Kafrawy; Tamer Hifnawy; Sameera Ezzat; Mohamed A Abdel-Aziz; Mohamed Saad Zaghloul; Saber Rafat Ali; Hussein Khaled; Sania Amr; Yun-Ling Zheng; Nabiel Mikhail; Christopher Loffredo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-17       Impact factor: 4.254

4.  GPX1 gene Pro200Leu polymorphism, erythrocyte GPX activity, and cancer risk.

Authors:  Zhiqiang Hong; Changwei Tian; Xingliang Zhang
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

5.  The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.

Authors:  Rafał Watrowski; Dan Cacsire Castillo-Tong; Gerhild Fabjani; Eva Schuster; Michael Fischer; Robert Zeillinger
Journal:  Tumour Biol       Date:  2015-08-12

6.  Relevance of selenoprotein transcripts for selenium status in humans.

Authors:  Edyta Reszka; Ewa Jablonska; Jolanta Gromadzinska; Wojciech Wasowicz
Journal:  Genes Nutr       Date:  2011-09-07       Impact factor: 5.523

7.  Dysregulation of Redox Status in Urinary Bladder Cancer Patients.

Authors:  Edyta Reszka; Monika Lesicka; Edyta Wieczorek; Ewa Jabłońska; Beata Janasik; Maciej Stępnik; Tomasz Konecki; Zbigniew Jabłonowski
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 8.  Role of Selenoprotein F in Protein Folding and Secretion: Potential Involvement in Human Disease.

Authors:  Bingyu Ren; Min Liu; Jiazuan Ni; Jing Tian
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.